Nominations & applications invited for CDRI awards in drug research development

CSIR-Central Drug Research Institute, Lucknow has instituted CDRI Awards to recognise scientific excellence in the country in the area of drug research and development.
These awards are given annually to Indian nationals below 45 years of age who are engaged in basic and applied research in the area having direct bearing on drug research and development and have made outstanding contributions with potential for application/ product and technology development.
There are two separate individual awards each for the area of Chemical Sciences and Life Sciences. Each award carries a cash prize of Rs. 20,000 and a citation.
Head of the Institutions/Organizations/Universities/Industries, Bhatnagar Awardees, Fellows of National Science Academies can nominate. Eligible candidates can also directly submit their application.
Word file of proforma for Nomination/application can be downloaded from http://www.cdri.res.in Complete information must reach CDRI by 31 December 2018 for consideration.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
“Did They Just Buy a Money Printer for ¥288 Million?”: Yip’s Chemical’s Bold Bet on Green Tech—Is This a Genuine Transformation or Just Another Story for the Stock Market?
-
Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients
-
Afidopyropen: The Silent Assassin of Sap-Sucking Pests—Promise, Pitfalls, and the Path to Sustainable Deployment
-
Agrochemical Markets at a Crossroads: Winter Stockpiling Begins Amid Cost Pressures and Fragmented Demand
-
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
Recommend Reading
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
Middle East Crude Exports Rebound Sharply in September as Saudi Arabia Returns to Market at 5.4 Million bpd
-
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
Chinese Asphalt Market Sees Limited Transactions Before the Festival, May Rise Moderately After the Festival
-
Insufficient Downstream Demand Puts Pressure on DMF Market
-
Pre-holiday Dichloromethane Price Increase Fails to Continue
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses
- Hot Searches
- gibberellic acid
- trisodium phosphate where to buy
- poly diallyldimethylammonium chloride
- phenylpiracetam hydrazide buy
- manganese sulfate hydrate
- polylactic acid cost
- enterobacter cloacae.
- retatrutide usa
- glacial acetic acid price
- price of graphite
- sr 17018 for sale 1 gram
- disulfur hexafluoride